231 related articles for article (PubMed ID: 31133278)
1. Seizures in patients with a phaeochromocytoma/paraganglioma (PPGL): A review of clinical cases and postulated pathological mechanisms.
Li Y; Zhang B
Rev Neurol (Paris); 2019 Oct; 175(9):495-505. PubMed ID: 31133278
[TBL] [Abstract][Full Text] [Related]
2. Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
Grigoryan S; Nhan W; Zhang L; Urban C; Zhao L; Turcu AF
J Clin Endocrinol Metab; 2023 May; 108(6):e343-e349. PubMed ID: 36469797
[TBL] [Abstract][Full Text] [Related]
3. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
Schreiner F; Beuschlein F
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study.
Ebbehoj A; Stochholm K; Jacobsen SF; Trolle C; Jepsen P; Robaczyk MG; Rasmussen ÅK; Feldt-Rasmussen U; Thomsen RW; Søndergaard E; Poulsen PL
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2251-e2261. PubMed ID: 33479747
[TBL] [Abstract][Full Text] [Related]
6. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytomas and Paragangliomas.
Tevosian SG; Ghayee HK
Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
[TBL] [Abstract][Full Text] [Related]
8. [Phaeochromocytoma and paraganglioma].
Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
[TBL] [Abstract][Full Text] [Related]
9. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.
Casey R; Neumann HPH; Maher ER
Hum Mol Genet; 2020 Oct; 29(R2):R128-R137. PubMed ID: 33059362
[TBL] [Abstract][Full Text] [Related]
10. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
11. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.
Bancos I; Atkinson E; Eng C; Young WF; Neumann HPH;
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):13-21. PubMed ID: 33248478
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
Meijs AC; Snel M; Corssmit EPM
Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy.
Clifton-Bligh RJ
Rev Endocr Metab Disord; 2023 Feb; 24(1):49-56. PubMed ID: 36637675
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation and treatment of phaeochromocytoma.
Davison AS; Jones DM; Ruthven S; Helliwell T; Shore SL
Ann Clin Biochem; 2018 Jan; 55(1):34-48. PubMed ID: 29027806
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.
Björklund P; Pacak K; Crona J
J Intern Med; 2016 Dec; 280(6):559-573. PubMed ID: 27165774
[TBL] [Abstract][Full Text] [Related]
16. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome - a systematic review.
Langton K; Tufton N; Akker S; Deinum J; Eisenhofer G; Timmers H; Spaanderman M; Lenders J
BJOG; 2021 Jul; 128(8):1264-1272. PubMed ID: 33342020
[TBL] [Abstract][Full Text] [Related]
18. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
Hamidi O
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
[TBL] [Abstract][Full Text] [Related]
19. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
20. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
